TherapeuticsMD, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementTherapeuticsMD, Inc. • March 4th, 2021 • Pharmaceutical preparations • New York
Company FiledMarch 4th, 2021 Industry JurisdictionTherapeuticsMD, Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: